Bayer | BAYN - Cost Of Sales


Bayer reported EUR4.54B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Air Liquide EUR 6.28B 378.3M Jun/2026
Akzo Nobel EUR 1.5B 95M Jun/2026
Alcon AG USD 1.12B 61M Jun/2026
Amarin USD 26.05M 1.41M Dec/2025
Arkema EUR 1.94B 144.9M Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
BASF EUR 12.87B 1.01B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Beiersdorf EUR 2.06B 50M Dec/2025
Corteva USD 2.91B 380M Jun/2026
Covestro EUR 2.7B 5.39B Dec/2025
Essilor EUR 5.55B 505M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
Genmab DKK 84M 19M Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Henkel EUR 4.99B 37M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Johnson Matthey GBP 6.9B 1.86B Jun/2026
Linde USD 4.52B 974M Mar/2026
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.27B 199M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Nutrien USD 7.56B 3.16B Jun/2026
Philips EUR 2.21B 70M Jun/2026
PPG Industries USD 2.69B 412M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
SAP EUR 2.65B 68M Jun/2026
Solvay EUR 928M 52M Jun/2026
UCB EUR 1.07B 146M Dec/2025
Umicore EUR 13.24B 3.49B Jun/2026
Vinci EUR 8.93B 1.22B Jun/2026